Drug Safety Information for CRIXIVAN (Indinavir sulfate)
Safety-related Labeling Changes for CRIXIVAN (INDINAVIR SULFATE) Rx Drug: FDA Link
Adverse Drug Reactions for CRIXIVAN* (Indinavir sulfate)
These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).
Top 20 Adverse Effects Associated with CRIXIVAN
(reported in FDA Medwatch/FAERS Reports)
Side Effect | # of FDA Reports | |
---|---|---|
1 | Lipodystrophy acquired | 95 |
2 | Nephrolithiasis* | 73 |
3 | Nausea* | 71 |
4 | Vomiting | 68 |
5 | Diarrhoea* | 64 |
6 | Pyrexia | 57 |
7 | Drug interaction | 49 |
8 | Aspartate aminotransferase increased | 49 |
9 | Immune reconstitution syndrome | 47 |
10 | Drug ineffective | 47 |
11 | Mitochondrial toxicity | 46 |
12 | Osteonecrosis | 46 |
13 | Eyelid ptosis | 44 |
14 | Alanine aminotransferase increased | 43 |
15 | Anaemia | 41 |
16 | Renal failure acute | 40 |
17 | Fatigue | 40 |
18 | Hypertriglyceridaemia | 39 |
19 | Weight decreased | 39 |
20 | Neutropenia | 39 |
* This side effect also appears in "Top 10 Side Effects of CRIXIVAN " in the drug's Review Summary based on AskaPatient reviews.
Top 10 Reasons for Taking CRIXIVAN
(associated with FDA Medwatch/FAERS Reports)
Reason | # of FDA Reports | |
---|---|---|
1 | Hiv infection | 3352 |
2 | Product used for unknown indication | 185 |
3 | Hiv test positive | 108 |
4 | Acquired immunodeficiency syndrome | 94 |
5 | Antiretroviral therapy | 61 |
6 | Prophylaxis against hiv infection | 61 |
7 | Maternal exposure during pregnancy | 53 |
8 | Ill-defined disorder | 33 |
9 | Prophylaxis | 32 |
10 | Human immunodeficiency virus transmission | 26 |
*Also a top-10 reason in AskaPatient Review Summary.
Types of Adverse Events for CRIXIVAN
Total Reports Filed with FDA: 5787
Number of FDA Adverse Event Reports by Patient Age for CRIXIVAN
Total Reports Filed with FDA: 5787*
* Reports for drugs with the same active ingredients have been aggregated in this analysis: Indinavir sulfate (Indinavir sulfate, Indinavir sulphate, Indinavir, Idv, Crixivan)
Charts are based on 5787 reports filed with the FDA between 2004 and June 2015.
Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.
Click to go back to search results and CRIXIVAN Reviews and Review Summary .
Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.